Trials / Unknown
UnknownNCT03170310
Apatinib Treatment for Advanced Esophagus Cancer
Apatinib Treatment for Advanced Esophagus Cancer ,One-armed，Exploratory，Openting , Clinical Trail.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Henan Cancer Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Subject ever received a standard chemotherapy solution progression or recurrence or can't tolerate chemotherapy with advanced esophageal squamous carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib | Apatinib500 mg,po,qd,continuous dosing until PD, death or not tolerated toxicity. |
Timeline
- Start date
- 2017-02-21
- Primary completion
- 2019-02-21
- Completion
- 2019-09-21
- First posted
- 2017-05-31
- Last updated
- 2017-05-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03170310. Inclusion in this directory is not an endorsement.